Rheumatology

Trials, guidelines and clinical evidence across Rheumatology.

Insufficient source text for gout prophylaxis safety article rewrite

The scraped source contains only the article title, so a safe rewrite cannot include study results, cohort size, or adverse-event findings.

By Dr. A. Nikhil Krishnan, MBBS · 7 days ago · 4 min read

Rheumatology·BBC Dental

Rheumatology dismissal ruling upheld after Jersey tribunal rejects claim

A Jersey tribunal upheld the dismissal of a doctor linked to a failed rheumatology service review, citing patient…

Nov 6, 2026

Rheumatology·ARD

Behçet’s syndrome miRNA profile points to thrombo-inflammation biomarker

Circulating miRNAs miR-224-5p, miR-206, and miR-653-5p distinguished Behçet’s syndrome from controls and linked to thrombo-inflammatory pathways.

Nov 6, 2026

Rheumatology·ARD

Axial spondyloarthritis study finds mental health and disease activity move together

Latent class analysis in axial spondyloarthritis found anxiety, depression, and disease activity tracked closely at baseline and after…

Nov 6, 2026

Rheumatology·ARD

EULAR imaging recommendations reshape diagnosis and management of crystal arthropathies

EULAR issues first imaging recommendations for gout and other crystal arthropathies, covering diagnosis, monitoring, treatment response and guided…

Nov 6, 2026

Rheumatology·ARD

TNF inhibitor use in RA pregnancy linked to higher birth weight

In a closely monitored rheumatoid arthritis cohort, TNF inhibitor use during pregnancy was associated with higher offspring birth…

Nov 6, 2026

Rheumatology·ARD

KL-6 and CA-125 biomarkers track progression in SSc-ILD SENSCIS

KL-6 identified faster FVC decline in SSc-ILD, while nintedanib lowered CA-125 and pro-C6 in SENSCIS biomarker analyses.

Nov 6, 2026

Rheumatology·ARD

Avacopan Improves Week 52 Outcomes in ANCA Vasculitis With Rituximab

In ADVOCATE, avacopan matched prednisone at week 26 and improved week 52 remission, renal recovery, and steroid toxicity…

Nov 6, 2026

Rheumatology·ARD

COVID-19 immunomodulatory therapies: EULAR review finds mixed evidence

EULAR’s systematic review found glucocorticoids improved survival in some COVID-19 subsets, while hydroxychloroquine failed and other agents remained…

Nov 6, 2026

Rheumatology·ARD

Rheumatoid Arthritis Radiographic Progression Splits Into Four Distinct Trajectories

Four radiographic progression patterns emerged in rheumatoid arthritis, with baseline CRP, disease duration, SHS and treatment status helping…

Nov 6, 2026

Rheumatology

Trials, guidelines and clinical evidence across Rheumatology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.